SI1272489T1 - Process for preparing crystalline form i of cabergoline - Google Patents

Process for preparing crystalline form i of cabergoline

Info

Publication number: SI1272489T1
Authority: SI; Slovenia
Prior art keywords: cabergoline; crystalline form; preparing crystalline; preparing; crystalline
Prior art date: 2000-03-24

Application number

SI200130045T

Other languages

English (en)

Slovenian (sl)

Inventor

Attilio Tomasi

Stefania Magenes

Mario Ungari

Giuliano Ramella

Gianfranco Pallanza

Original Assignee

Pharmacia Italia S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-24

Filing date

2001-03-19

Publication date

2004-02-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9888433&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1272489(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-03-19 Application filed by Pharmacia Italia S.P.A. filed Critical Pharmacia Italia S.P.A.

2004-02-29 Publication of SI1272489T1 publication Critical patent/SI1272489T1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Hematology (AREA)
Psychology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SI200130045T 2000-03-24 2001-03-19 Process for preparing crystalline form i of cabergoline SI1272489T1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0007308.0A GB0007308D0 (en)	2000-03-24	2000-03-24	Process for preparing crystalline form \| of cabergoline
PCT/EP2001/003099 WO2001070740A1 (en)	2000-03-24	2001-03-19	Process for preparing crystalline form i of cabergoline

Publications (1)

Publication Number	Publication Date
SI1272489T1 true SI1272489T1 (en)	2004-02-29

Family

ID=9888433

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200130045T SI1272489T1 (en)	2000-03-24	2001-03-19	Process for preparing crystalline form i of cabergoline

Country Status (31)

Country	Link
US (2)	US6727363B2 (xx)
EP (1)	EP1272489B1 (xx)
JP (1)	JP4184666B2 (xx)
KR (1)	KR100827558B1 (xx)
CN (1)	CN1188412C (xx)
AR (1)	AR032449A1 (xx)
AT (1)	ATE250601T1 (xx)
AU (2)	AU780747B2 (xx)
BR (1)	BR0109507A (xx)
CA (1)	CA2402836A1 (xx)
CZ (1)	CZ20023176A3 (xx)
DE (1)	DE60100858T2 (xx)
DK (1)	DK1272489T3 (xx)
EA (1)	EA005928B1 (xx)
EE (1)	EE05088B1 (xx)
ES (1)	ES2208602T3 (xx)
GB (1)	GB0007308D0 (xx)
HK (1)	HK1052348B (xx)
HU (1)	HUP0300591A3 (xx)
IL (2)	IL150985A0 (xx)
MX (1)	MXPA02009283A (xx)
MY (1)	MY134189A (xx)
NO (1)	NO20024321D0 (xx)
NZ (1)	NZ521316A (xx)
PE (1)	PE20011140A1 (xx)
PL (1)	PL358253A1 (xx)
PT (1)	PT1272489E (xx)
SI (1)	SI1272489T1 (xx)
SK (1)	SK13582002A3 (xx)
WO (1)	WO2001070740A1 (xx)
ZA (1)	ZA200206045B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0007307D0 (en) *	2000-03-24	2000-05-17	Pharmacia & Upjohn Spa	Crystalline form \|\| of cabergoline
GB0007308D0 (en) *	2000-03-24	2000-05-17	Pharmacia & Upjohn Spa	Process for preparing crystalline form \| of cabergoline
DE10043321B4 (de) *	2000-08-24	2005-07-28	Neurobiotec Gmbh	Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) *	2000-10-20	2002-05-02	Schering Ag	Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) *	2000-12-16	2002-07-04	Schering Ag	Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
CA2478149A1 (en) *	2002-03-15	2003-09-25	Pharmacia Corporation	Process for preparing crystalline form i of cabergoline
EP1485383A1 (en) *	2002-03-15	2004-12-15	Pharmacia Corporation	Process for preparing crystalline form i of cabergoline
IL155545A (en) *	2003-04-21	2009-12-24	Finetech Pharmaceutical Ltd	Solvate form of cabergoline
KR20060028761A (ko) *	2003-05-08	2006-04-03	아이박스 파마슈티컬스 에스.알.오.	다형의 카베르골린
GB0409785D0 (en) *	2004-04-30	2004-06-09	Resolution Chemicals Ltd	Preparation of cabergoline
GB0515430D0 (en) *	2005-07-27	2005-08-31	Resolution Chemicals Ltd	Preparation of cabergoline
GB0505965D0 (en)	2005-03-23	2005-04-27	Resolution Chemicals Ltd	Preparation of cabergoline
US7339060B2 (en)	2005-03-23	2008-03-04	Resolution Chemicals, Ltd.	Preparation of cabergoline
EP1925616A1 (en) *	2006-10-26	2008-05-28	LEK Pharmaceuticals D.D.	Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
EP1953157A1 (en)	2007-01-31	2008-08-06	LEK Pharmaceuticals D.D.	New crystal form of cabergoline
WO2009027086A2 (en) *	2007-08-29	2009-03-05	Max Zeller Söhne Ag	Use of vitex agnus castus extracts for preparing a medicament
EP4074552B1 (en) *	2021-04-16	2024-04-03	Thermo King LLC	Electrical connection unit

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3019322A1 (de)	1980-05-21	1981-12-03	Merck Patent Gmbh, 6100 Darmstadt	Psychopharmakon sowie verwendung von adenosinderivaten
US4526892A (en) *	1981-03-03	1985-07-02	Farmitalia Carlo Erba, S.P.A.	Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
GB2103603B (en) *	1981-08-11	1985-04-11	Erba Farmitalia	Ergoline derivatives
GB9205439D0 (en)	1992-03-12	1992-04-22	Erba Carlo Spa	Process for the synthesis of ergoline derivatives
EP0664705B1 (en)	1993-08-18	2000-10-04	Alcon Laboratories, Inc.	Compositions of ergoline derivatives for the treatment of glaucoma
WO1999036095A1 (en)	1998-01-13	1999-07-22	Astrazeneca Uk Limited	PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D2) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING β2-ADRENORECEPTOR AGONIST ACTIVITY
PL343593A1 (en)	1998-03-27	2001-08-27	Upjohn Co	Use of cabergoline in the treatment of restless legs syndrome
GB0007308D0 (en)	2000-03-24	2000-05-17	Pharmacia & Upjohn Spa	Process for preparing crystalline form \| of cabergoline
GB0007309D0 (en)	2000-03-24	2000-05-17	Pharmacia & Upjohn Spa	Crystalline form V\|\| of cabergoline
GB0007307D0 (en)	2000-03-24	2000-05-17	Pharmacia & Upjohn Spa	Crystalline form \|\| of cabergoline

2000
- 2000-03-24 GB GBGB0007308.0A patent/GB0007308D0/en not_active Ceased
2001
- 2001-03-13 PE PE2001000237A patent/PE20011140A1/es not_active Application Discontinuation
- 2001-03-19 AU AU62110/01A patent/AU780747B2/en not_active Ceased
- 2001-03-19 AT AT01936098T patent/ATE250601T1/de not_active IP Right Cessation
- 2001-03-19 KR KR1020027012590A patent/KR100827558B1/ko not_active IP Right Cessation
- 2001-03-19 PT PT01936098T patent/PT1272489E/pt unknown
- 2001-03-19 CN CNB018070051A patent/CN1188412C/zh not_active Expired - Fee Related
- 2001-03-19 PL PL01358253A patent/PL358253A1/xx not_active Application Discontinuation
- 2001-03-19 EP EP01936098A patent/EP1272489B1/en not_active Expired - Lifetime
- 2001-03-19 JP JP2001568941A patent/JP4184666B2/ja not_active Expired - Fee Related
- 2001-03-19 ES ES01936098T patent/ES2208602T3/es not_active Expired - Lifetime
- 2001-03-19 BR BR0109507-2A patent/BR0109507A/pt not_active Application Discontinuation
- 2001-03-19 NZ NZ521316A patent/NZ521316A/en unknown
- 2001-03-19 SI SI200130045T patent/SI1272489T1/xx unknown
- 2001-03-19 DE DE60100858T patent/DE60100858T2/de not_active Expired - Fee Related
- 2001-03-19 EE EEP200200545A patent/EE05088B1/xx not_active IP Right Cessation
- 2001-03-19 IL IL15098501A patent/IL150985A0/xx active IP Right Grant
- 2001-03-19 SK SK1358-2002A patent/SK13582002A3/sk unknown
- 2001-03-19 WO PCT/EP2001/003099 patent/WO2001070740A1/en active IP Right Grant
- 2001-03-19 CZ CZ20023176A patent/CZ20023176A3/cs unknown
- 2001-03-19 HU HU0300591A patent/HUP0300591A3/hu unknown
- 2001-03-19 MX MXPA02009283A patent/MXPA02009283A/es active IP Right Grant
- 2001-03-19 CA CA002402836A patent/CA2402836A1/en not_active Withdrawn
- 2001-03-19 US US10/239,636 patent/US6727363B2/en not_active Expired - Fee Related
- 2001-03-19 DK DK01936098T patent/DK1272489T3/da active
- 2001-03-19 AR ARP010101263A patent/AR032449A1/es unknown
- 2001-03-19 EA EA200201016A patent/EA005928B1/ru unknown
- 2001-03-22 MY MYPI20011364A patent/MY134189A/en unknown
2002
- 2002-07-29 ZA ZA200206045A patent/ZA200206045B/xx unknown
- 2002-07-30 IL IL150985A patent/IL150985A/en not_active IP Right Cessation
- 2002-09-10 NO NO20024321A patent/NO20024321D0/no not_active Application Discontinuation
2003
- 2003-06-25 HK HK03104554.7A patent/HK1052348B/zh not_active IP Right Cessation
- 2003-10-31 US US10/698,737 patent/US6953854B2/en not_active Expired - Fee Related
2005
- 2005-07-14 AU AU2005203071A patent/AU2005203071B2/en not_active Ceased

Also Published As

Publication number	Publication date
ATE250601T1 (de)	2003-10-15
DE60100858D1 (de)	2003-10-30
EE200200545A (et)	2004-04-15
PT1272489E (pt)	2004-02-27
DK1272489T3 (da)	2003-12-15
HUP0300591A2 (hu)	2003-07-28
CN1419554A (zh)	2003-05-21
EP1272489A1 (en)	2003-01-08
MY134189A (en)	2007-11-30
US6727363B2 (en)	2004-04-27
PL358253A1 (en)	2004-08-09
AU6211001A (en)	2001-10-03
HK1052348B (zh)	2005-09-16
ES2208602T3 (es)	2004-06-16
KR100827558B1 (ko)	2008-05-07
EA005928B1 (ru)	2005-08-25
WO2001070740A1 (en)	2001-09-27
AU2005203071A1 (en)	2005-08-11
CZ20023176A3 (cs)	2003-02-12
IL150985A (en)	2007-03-08
AU2005203071B2 (en)	2007-10-18
AU780747B2 (en)	2005-04-14
NO20024321L (no)	2002-09-10
PE20011140A1 (es)	2001-11-01
US20030149067A1 (en)	2003-08-07
HUP0300591A3 (en)	2009-01-28
IL150985A0 (en)	2003-02-12
US6953854B2 (en)	2005-10-11
SK13582002A3 (sk)	2003-04-01
DE60100858T2 (de)	2004-07-29
EE05088B1 (et)	2008-10-15
EP1272489B1 (en)	2003-09-24
JP4184666B2 (ja)	2008-11-19
NZ521316A (en)	2004-05-28
CN1188412C (zh)	2005-02-09
US20040092744A1 (en)	2004-05-13
GB0007308D0 (en)	2000-05-17
KR20020081587A (ko)	2002-10-28
JP2003528100A (ja)	2003-09-24
NO20024321D0 (no)	2002-09-10
EA200201016A1 (ru)	2003-02-27
BR0109507A (pt)	2002-12-10
CA2402836A1 (en)	2001-09-27
MXPA02009283A (es)	2003-03-12
AR032449A1 (es)	2003-11-12
HK1052348A1 (en)	2003-09-11
ZA200206045B (en)	2003-07-29

Publication	Publication Date	Title
IL150985A0 (en)	2003-02-12	Process for preparing crystalline form i of cabergoline
EP1425279A4 (en)	2005-10-26	PROCESS FOR THE PREPARATION OF CRYSTALLINE TETRAHYDROBENZOTHIEPINES
EP1331233A4 (en)	2004-05-19	METHOD FOR PRODUCING A POLYISOCYANATE COMPOSITION
EG23819A (en)	2007-09-19	Method for preparing of l-phenylephrine-hydrochloride
HUP0202097A2 (en)	2002-10-28	Process for preparing substituted cyclopentane derivatives and novel crystalline form of these derivatives
GB0016002D0 (en)	2000-08-23	Novel process for preparing crystalline particles
GB0007307D0 (en)	2000-05-17	Crystalline form \|\| of cabergoline
SG99351A1 (en)	2003-10-27	Process for the manufacture of a crystalline solid
HUP0300160A3 (en)	2005-07-28	Process for preparing (+)-cis-sertraline
GB0007309D0 (en)	2000-05-17	Crystalline form V\|\| of cabergoline
IL163520A0 (en)	2005-12-18	Process for preparing crystalline form i of cabergoline
HUP0303907A3 (en)	2012-09-28	Improved process for preparation of steroids
IL163779A0 (en)	2005-12-18	Process for preparing crystalline form i of cabergoline
HUP0101875A3 (en)	2002-11-28	Process for the preparation of piperidine derivatives
HUP0303832A3 (en)	2005-02-28	Process for preparation of baccatin iii derivatives
HU0101722D0 (en)	2001-07-30	Process for producing of chocolate
HUP0203364A3 (en)	2005-11-28	Method for preparation of 3-substituted-4-arylquinolin-2-one derivatives
AU2001289303A1 (en)	2002-02-18	Process for producing crystalline tagatose
IL151632A0 (en)	2003-04-10	Process for preparing pure crystalline lorazepam
HU0104563D0 (en)	2002-01-28	Process for producing of food-enzymes
HUP0001408A2 (hu)	2001-12-28	Eljárás takarmánymagok előállítására
HUP0004469A3 (en)	2002-08-28	Process for producing trifluormethyl-aniline derivatives
HUP0000208A3 (en)	2002-02-28	Process for producing secondary-alkoxy-1-alkene derivatives
HU9904575D0 (en)	2000-02-28	Process for preparation of n-alkoxy-methyl-acidamides
GB0016016D0 (en)	2000-08-23	Novel process for preparing crystalline particles